![Kenichi Akamatsu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenichi Akamatsu
Chief Executive Officer at Megakaryon Corp.
Network origin in Kenichi Akamatsu first degree
Entity | Entity type | Industry | |
---|---|---|---|
Okayama University
8
| College/University | Other Consumer Services | 8 |
Megakaryon Corp.
![]() Megakaryon Corp. Medical/Nursing ServicesHealth Services Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan.
2
| Subsidiary | Medical/Nursing Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kenichi Akamatsu via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
KBI Biopharma, Inc.
![]() KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member | |
SUMITOMO ELECTRIC INDUSTRIES, LTD. | Electrical Products | Corporate Officer/Principal | |
The Iyo Bank Ltd.
![]() The Iyo Bank Ltd. Regional BanksFinance The Iyo Bank Ltd. engages in the provision of banking and leasing services. It operates through the following segments: Banking, Leasing, and Others. The Banking segment offers banking services such as deposits, loans, securities investments, and foreign exchange. The Leasing segment handles leasing business through its subsidiary. The Others segment includes information processing contract, software development, and securities businesses. The company was founded on March 15, 1878 and is headquartered in Matsuyama, Japan. | Regional Banks | Director/Board Member | |
JFE Shoji Corp.
![]() JFE Shoji Corp. Wholesale DistributorsDistribution Services JFE Shoji Corp. engages in the import, export, and domestic and foreign trade of steel products and steel raw materials. It provides iron ores, coals, ferrous alloys, steel scraps, steel plates, and steel pipes. It also deals with ship, food, and electronics businesses. The company was founded on January 5, 1954 and is headquartered in Tokyo, Japan. | Wholesale Distributors | Corporate Officer/Principal | |
TECHNO ASSOCIE CO., LTD. | Wholesale Distributors | President | |
Morishita Co., Ltd.
![]() Morishita Co., Ltd. Home FurnishingsConsumer Durables Morishita Co., Ltd. is engaged in the planning, development, import, manufacture and sales of pillows, cushions, rattan products, covers, other beddings and interior products. The company was founded in October 1953 and is headquartered in Osaka, Japan. | Home Furnishings | Chief Tech/Sci/R&D Officer | |
PT SUMI INDO KABEL TBK | Telecommunications Equipment | Chief Executive Officer | |
IDEMITSU KOSAN CO., LTD. | Oil Refining/Marketing | Corporate Officer/Principal | |
Monsanto Japan Ltd.
![]() Monsanto Japan Ltd. Chemicals: AgriculturalProcess Industries Part of Bayer AG, Monsanto Japan Ltd. is a Japanese company that manufactures a wide range of genetically altered seeds, fertilizers, and agrochemicals. The company is based in Tokyo, Japan. | Chemicals: Agricultural | Corporate Officer/Principal | |
University of Tokyo | College/University | Graduate Degree Undergraduate Degree | |
Bain & Co. Japan, Inc. | Corporate Officer/Principal | ||
IMMUNO-BIOLOGICAL LABORATORIES CO., LTD. | Medical Specialties | Director/Board Member | |
Immunas Pharma, Inc.
![]() Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Pharmaceuticals: Major | Chief Operating Officer | |
Eli Lilly Japan KK
![]() Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Japan KK is a Japanese company that manufactures and trades pharmaceutical products. The company is based in Kobe, Japan. | Pharmaceuticals: Major | Director/Board Member | |
GE Healthcare Asia | Corporate Officer/Principal | ||
SENSHU IKEDA HOLDINGS, INC. | Major Banks | President | |
CHIOME BIOSCIENCE INC. | Biotechnology | Director/Board Member | |
Fast Track Initiative, Inc.
![]() Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States. | Investment Managers | Founder | |
Sumitomo Electric Industrial Wire & Cable, Inc. | President | ||
INPEX Idemitsu Norge AS
![]() INPEX Idemitsu Norge AS Oil & Gas ProductionEnergy Minerals INPEX Idemitsu Norge AS engages in exploration, development and production of crude oil and natural gas. The company was founded on September 25, 1989 and is headquartered in Oslo, Norway. | Oil & Gas Production | Corporate Officer/Principal | |
Innovation Network Corporation of Japan, Ltd.
![]() Innovation Network Corporation of Japan, Ltd. Investment ManagersFinance The Innovation Network Corporation of Japan (INCJ), a unique public-private partnership aimed at promoting innovation and enhancing the value of businesses in Japan, was launched in July 2009. Leveraging the rich history of Japanese technological prowess, the INCJ aims to provide financial, technological and management support in order to promote the creation of next-generation businesses through 'open innovation,' or the flow of technology and expertise beyond the boundaries of existing organizational structures. The INCJ will draw on funding as well as management and technological expertise from the public and private sectors. The INCJ is actively reviewing various investment opportunities in areas of environment and energy, electronics and IT, bio-tech, and infrastructure such as water supply, railway service, and nuclear power supply. Each investment will be thoroughly vetted to ensure it meets the exacting standards of the INCJ's Innovation Network Committee, which will make the final investment decisions. The INCJ is capitalized at 92 billion yen, with the Japanese government injecting 82 billion yen and 19 private corporations (refer to details in Appendix below) providing a further 10 billion yen. The government will also provide guarantees up to a total of 800 billion yen for INCJ investments, giving it an investment capability of approximately 900 billion yen (US$10 billion). The INCJ will be established for a period of 15 years. | Investment Managers | Private Equity Investor | |
The Senshu Ikeda Bank Ltd.
![]() The Senshu Ikeda Bank Ltd. Major BanksFinance Part of Senshu Ikeda Holdings, Inc., The Senshu Ikeda Bank Ltd. is a commercial bank based in Osaka, Japan. The Senshu Ikeda Bank provides commercial banking services. The Japanese company was founded in 1951. Atsushi Ukawa has been the CEO of the company since 1980. | Major Banks | President | |
Japan Medical Information Research Institute, Inc.
![]() Japan Medical Information Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Japan Medical Information Research Institute, Inc. engages in the collection, analysis, marketing, and consulting of medical information. The company was founded on July 14, 2005 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
NapaJen Pharma, Inc.
![]() NapaJen Pharma, Inc. Pharmaceuticals: MajorHealth Technology NapaJen Pharma, Inc. develops drug delivery technology solutions through cellular transport pathways. Its products include lead platform and drug delivery. The firm specializes in the development of novel drug delivery systems by utilizing natural transport pathways whose cells are used to move molecular cargo into themselves and across internal compartments. The company was founded by Dr. Kazuo Sakurai and Hironori Ando in December 2004 and is headquartered in Burlingame, CA. | Pharmaceuticals: Major | Director/Board Member | |
PT MITRABARA ADIPERDANA TBK | Coal | Director/Board Member | |
PRISM BioLab Co., Ltd.
![]() PRISM BioLab Co., Ltd. BiotechnologyHealth Technology PRISM Pharma Co., Ltd. operates as a pharmaceutical company that focuses on discovery and development of small molecules to modulate protein-protein interactions. It utilizes protein secondary structure mimetic library, which modulates intracellular protein and protein interactions. The firm develops an anti-cancer drug CP/Catenin inhibitor PRI-724 that acts on both cancer cells and cancer stem cells that can switch from proliferation to differentiation. The company was founded by Hiroyuki Kouji on November 2, 2006 and is headquartered in Fujisawa, Japan. | Biotechnology | Director/Board Member | |
Senshu Ikeda Investment Management Co. Ltd.
![]() Senshu Ikeda Investment Management Co. Ltd. Investment ManagersFinance Senshu Ikeda Investment Management Co. Ltd. (Senshu Ikeda) is an investment management firm headquartered in Osaka, Japan. The firm was founded in 1987 and is a subsidiary of The Senshu Ikeda Bank Ltd., which is owned by Senshu Ikeda Holdings, Inc. (TYO: 8714). Senshu Ikeda provides investment management services to Japanese investors. | Investment Managers | President | |
Quantum Biosystems, Inc.
![]() Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Biotechnology | Director/Board Member | |
Atonarp, Inc.
![]() Atonarp, Inc. Medical SpecialtiesHealth Technology Atonarp, Inc. provides chemical analysis solutions and systems. The firm develops the Smart Spectrometer technology that focus on industrial gas process analytics applications in the energy, pharmaceutical, petrochemical and semiconductor industries. The company was founded by Tomoyoshi Sato and Prakash S. Murthy in November 2009 and is headquartered in Minato-Ku, Japan. | Medical Specialties | Director/Board Member | |
SCOHIA PHARMA, Inc.
![]() SCOHIA PHARMA, Inc. Miscellaneous Commercial ServicesCommercial Services SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe. | Miscellaneous Commercial Services | Director/Board Member | |
Junten Bio Co. Ltd.
![]() Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan. | Miscellaneous Commercial Services | President | |
KIDSWELL BIO CORPORATION | Biotechnology | President |
Statistics
International
Japan | 32 |
United States | 4 |
Indonesia | 3 |
Norway | 2 |
Sectoral
Health Technology | 14 |
Finance | 8 |
Commercial Services | 5 |
Energy Minerals | 4 |
Distribution Services | 3 |
Operational
Director/Board Member | 22 |
Corporate Officer/Principal | 11 |
President | 7 |
Graduate Degree | 7 |
Undergraduate Degree | 4 |
Most connected contacts
- Stock Market
- Insiders
- Kenichi Akamatsu
- Company connections